chr9-79718839-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_007005.6(TLE4):c.1458C>T(p.His486=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00138 in 1,614,132 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0076 ( 15 hom., cov: 32)
Exomes 𝑓: 0.00074 ( 12 hom. )
Consequence
TLE4
NM_007005.6 synonymous
NM_007005.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.00100
Genes affected
TLE4 (HGNC:11840): (TLE family member 4, transcriptional corepressor) Predicted to enable transcription corepressor activity. Predicted to be involved in negative regulation of canonical Wnt signaling pathway. Predicted to act upstream of or within Wnt signaling pathway; cellular response to leukemia inhibitory factor; and negative regulation of transcription by RNA polymerase II. Located in nucleoplasm. Part of beta-catenin-TCF complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 9-79718839-C-T is Benign according to our data. Variant chr9-79718839-C-T is described in ClinVar as [Benign]. Clinvar id is 786909.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.001 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00759 (1156/152244) while in subpopulation AFR AF= 0.0265 (1099/41532). AF 95% confidence interval is 0.0252. There are 15 homozygotes in gnomad4. There are 573 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1156 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TLE4 | NM_007005.6 | c.1458C>T | p.His486= | synonymous_variant | 15/20 | ENST00000376552.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TLE4 | ENST00000376552.8 | c.1458C>T | p.His486= | synonymous_variant | 15/20 | 1 | NM_007005.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00760 AC: 1156AN: 152126Hom.: 15 Cov.: 32
GnomAD3 genomes
AF:
AC:
1156
AN:
152126
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00195 AC: 491AN: 251484Hom.: 4 AF XY: 0.00148 AC XY: 201AN XY: 135912
GnomAD3 exomes
AF:
AC:
491
AN:
251484
Hom.:
AF XY:
AC XY:
201
AN XY:
135912
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000738 AC: 1079AN: 1461888Hom.: 12 Cov.: 31 AF XY: 0.000683 AC XY: 497AN XY: 727244
GnomAD4 exome
AF:
AC:
1079
AN:
1461888
Hom.:
Cov.:
31
AF XY:
AC XY:
497
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00759 AC: 1156AN: 152244Hom.: 15 Cov.: 32 AF XY: 0.00770 AC XY: 573AN XY: 74432
GnomAD4 genome
AF:
AC:
1156
AN:
152244
Hom.:
Cov.:
32
AF XY:
AC XY:
573
AN XY:
74432
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Invitae | Aug 16, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at